VTGN (VTGN) Stock Price & Analysis
VTGN (VTGN) fell 1.38% to USD 0.24 as of September 8, 2026 at 09:01 UTC, according to Nexqual real-time market data.
VTGN last closed at USD 0.24; the session ranged USD 0.24–0.26 on volume of 347,258 shares. Market capitalization is —, with a 52-week range of USD 0.2–5.14 (NCM). Source: Nexqual, September 8, 2026 at 09:01 UTC.
Key Statistics (as of September 8, 2026 at 09:01 UTC)
| Price | USD 0.24 |
|---|---|
| Change | ▼ 1.38% (down) |
| Previous Close | USD 0.24 |
| Open | USD 0.24 |
| Day Range | USD 0.24 – 0.26 |
| 52-Week Range | USD 0.2 – 5.14 |
| Volume | 347,258 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (VTGN)
Nexqual's technical model rates VTGN "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:01 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 46.15 (neutral) |
| vs SMA50 | Below (USD 0.27) |
| MACD | -0.01 (negative) |
From VTGN's Latest SEC 10-K Filing (filed 2026-06-15)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VTVT | vTv Therapeutics Inc. | USD 33.35 | ▼ 0.15% |
| OTLK | Outlook Therapeutics, Inc. | USD 0.67 | ▲ 6.39% |
| TENX | Tenax Therapeutics, Inc. | USD 1.94 | ▲ 4.86% |
| XBIO | Xenetic Biosciences, Inc. | USD 4.67 | ▲ 9.88% |
| VSTM | Verastem, Inc. | USD 8.2 | ▲ 2.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:01 UTC. This page is informational and not investment advice.